BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9196428)

  • 1. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.
    Oudejans JJ; Jiwa NM; Meijer CJ
    J Pathol; 1997 Apr; 181(4):353-6. PubMed ID: 9196428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of major histocompatibility complex class I and LMP1 in Epstein-Barr virus-positive Hodgkin's lymphoma in a pediatric age group.
    Aybar A; Krause JR
    Microsc Res Tech; 2005 Nov; 68(3-4):247-9. PubMed ID: 16276512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease.
    Khan G; Coates PJ
    J Pathol; 1994 Nov; 174(3):141-9. PubMed ID: 7823246
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
    Herbst H; Raff T; Stein H
    J Pathol; 1996 May; 179(1):54-9. PubMed ID: 8691346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
    Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
    Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.
    Kordek R; Biernat W; Kupnicka D; Woźniak L
    Pol J Pathol; 1994; 45(4):279-81. PubMed ID: 7697330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus in Hodgkin's disease.
    Herbst H
    Semin Cancer Biol; 1996 Aug; 7(4):183-9. PubMed ID: 8946602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
    Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.
    Alkan S; Ross CW; Hanson CA; Schnitzer B
    Mod Pathol; 1995 Jun; 8(5):544-7. PubMed ID: 7675775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
    Herbst H; Samol J; Foss HD; Raff T; Niedobitek G
    J Pathol; 1997 Jul; 182(3):299-306. PubMed ID: 9349232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.
    Kanavaros P; Sakalidou A; Gaulard P; Jiwa M; Delides G; Tzardi M; Kalmantis T; Lydaki E; Kazlaris E; Kalmanti M
    Acta Morphol Hung; 1992; 40(1-4):223-30. PubMed ID: 1365766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Hodgkin's disease Reed-Sternberg cells and normal B-lymphocytes are infected by related Epstein-Barr virus strains.
    Faumont N; Trempat P; Brousset P; Delsol G; Meggetto F
    Virus Res; 2004 May; 101(2):163-73. PubMed ID: 15041184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Presence of human cytomegalovirus within the neoplastic cells of Hodgkin's disease].
    Huang GS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):403-5. PubMed ID: 12940088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.
    Meij P; Vervoort MB; Bloemena E; Schouten TE; Schwartz C; Grufferman S; Ambinder RF; Middeldorp JM
    J Med Virol; 2002 Nov; 68(3):370-7. PubMed ID: 12226824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease.
    Dukers DF; Jaspars LH; Vos W; Oudejans JJ; Hayes D; Cillessen S; Middeldorp JM; Meijer CJ
    J Pathol; 2000 Feb; 190(2):143-9. PubMed ID: 10657011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of heat shock protein 70 (HSP70) and EBV latent membrane protein 1 (LMP1) in Reed-Sternberg cells of Hodgkin's disease.
    Takahashi H; Fujita S; Shibata Y; Tsuda N; Okabe H
    Anal Cell Pathol; 1996 Nov; 12(2):71-83. PubMed ID: 8986292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease.
    Jarrett RF; MacKenzie J
    Semin Hematol; 1999 Jul; 36(3):260-9. PubMed ID: 10462326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.